U.S. Markets open in 9 hrs 14 mins

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
11.92+0.02 (+0.17%)
At close: 4:00PM EDT
People also watch
ZIOPFOLDACADCLDXACHN
  • E
    Eric1987
    Eric1987
    Royalties alone are up 20%! from last year .. come on guys
  • E
    Eric1987
    Eric1987
    The Earnings report was WAY better then what everyone here was thinking AKA the shorts... This has WINNER all over it. next JNJ. $$
  • S
    Sandy
    Sandy
    Will be trading back in the single digits soon.
  • S
    Sandy
    Sandy
    Keep shorting this Pig
  • M
    Michael
    Michael
    Just the usual. Low royalties. Huge expenditure. No news and basically nothing due. This is going down.
  • p
    paul
    paul
    Check your monthly chart. I would be surprised if 12.26 is not the bottom.
  • M
    Michael
    Michael
    More of the same today no doubt. Disappointing partner royalties - are Shire selling any HyQ? Huge expenditure mainly on the endless PEG trials. Yet again no news on those trials - whatever happpened to the promised interim readouts on the
  • J
    JANET
    JANET
    I find it interesting that Halo has not commented on or updated their website of the addition of Rituxan Hycela as a product they are part of. I was worried about this, but found it advertised on Genentech. I would have thought they would have at least updated their website. Any thoughts?
  • M
    MARK
    MARK
    Way oversold,they're hiring on a weekly basis.Something big in the woks
  • G
    George
    George
    earnings tomorrow, should be interesting................present on Thursday, maybe stock poised for a little run, would be nice.
  • P
    Paul
    Paul
    Eat dung HALO! Bwahahahahaha!
    Imagepareidoliaaa
  • G
    George
    George
    Shorts have it right now, should go to $10 after earnings, but still have drugs in the pipeline, will be short term pain, will lose 30% or so and then get back to $12 by end of year.
  • R
    Rodrique
    Rodrique

    This is where I find the top NASDAQ & NYSE Trade Ideas ---> www.T0pm@rketgainers.c0m

  • S
    Sandy
    Sandy
    Many other biotechs reaching New highs with a promising line of drugs while HALO usvstuck in the doldrums.
  • S
    Sandy
    Sandy
    Punish the monkey.
  • C
    Crecy
    Crecy
    HALO, ... Hummmmmm..........you guys watch AVEO today? It's heading to $4 on a Recommendation for Approval of it's Renal Cancer drug Tivo,, Approval day is SOON, end of Aug. Still time to ACCUMULATE.
  • G
    George
    George
    bio-tech stocks trade on FDA approvals, not quarterly earnings reports, unless stock in money woes, the earnings are meaningless, it is what is in the pipeline.
  • P
    Paul
    Paul
    CEO of HALO.....Always looking to innovate!!! Your money? Don't worry! Now you see it, now you don't!!!
    Imagedennsokagi
  • P
    Paul
    Paul
    Here goes your investment!!!
    Imagerexisky
  • J
    JANET
    JANET
    I am expecting that HALO received a milestone payment for FDA approval of rituximab. If this is the case, it should help improve the loss per share this past quarter and might give some short term momentum around earnings time. Does anyone know the details of any milestone payment if any? Also, I suspect that any company's forecasting of EPS going forward has not taken into account rituximab until it was approved. I suspect forward guidance may be better (offset by starting two new studies). Any info on this?